glp-1 for diabetes type 2 drugs are all approved glucose control in (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, and obesity. None Targeting GLP-1, GIP & GCG

Compounded formulations with niacinamide have not been specifically studied, so whether the additive provides additional weight loss is unknown

With 1 in every 166 child born with autism , it's imperative to protect the developing fetus at all cost

figures used for popular research compounds such as BPC-157 or TB-500 are drawn from preclinical animal studies, not approved human protocols

When appropriate, theyre prescribed by a provider, sourced through a trusted compounding pathway, dosed individually, and monitored with a candid discussion of the evidence

Unpredictable results : A compromised dose might lead to fewer benefits or worse, side effectsif the active ingredient becomes unstable